Health
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals – Fintech Zoom
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individuals –
Sinovac – Phase I/II trial findings support use of CoronaVac vaccine in older individualsResearchers in China have reported phase I/II clinical trial findings showing that the vaccine candidate CoronaVac is well tolerated among older individuals and effectively generates antibody responses against severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
CoronaVac is an inactivated SARS-CoV-2 vaccine developed by Chinese pharmaceutical…
-
General14 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News24 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News13 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General23 hours agoDe Minaur to face Djokovic at Wimbledon, as Kasatkina bows out in straight sets